STANDARD OPERATING PROCEDURE

Size: px
Start display at page:

Download "STANDARD OPERATING PROCEDURE"

Transcription

1 Document No.: SOP-XXXX Revision: XX Page 1 of OBJECTIVE 1.1 To comply with the requirement of policy XYZ on revalidation/requalification. 1.2 To outline the procedure by which the Validation Services Department periodically evaluates the performance of previously validated facilities, equipment, systems, and processes. This evaluation includes a periodic review of performed critical changes/repairs. Reviews will be performed to determine the impact to the validated state of the facilities, equipment, systems, and processes. The objective of the program is to verify that systems continue to operate within the criteria established in the original validation and according to current Company guidelines. 2. SCOPE 2.1 This procedure applies to previously validated facilities, equipment, systems, and processes that are used to manufacture or to support the manufacture of pharmaceutical products intended for clinical or commercial distribution at XXXXX facilities Planned and emergency changes to validated facilities, equipment, systems, and processes are documented and evaluated via the Change Control system (SOP- XXXX). 2.2 Critical changes/repairs to facilities, equipment, systems, and processes are documented in the Critical Changes/Repairs database (e.g., Maximo, EQMS). Review of the database involves identifying the Critical Change/Repair performed by equipment name, service manager, system association, technician, ID number, work order number, or author. The database includes Changes/Repairs from Buildings 001, 002, 003, and REFERENCES The Critical Change Review (CCR) will include applicable Change Control, Preventive Maintenance Interval Evaluation, Maintenance Work Orders, and Quarterly EM Trend Report Review (where applicable). 3.1 SDSOP-XXXX 4. RESPONSIBILITY 4.1 The Validation group is responsible for verifying that facilities, equipment, systems, and processes used in the manufacture of product for clinical or commercial distribution remains in a validated state. 4.2 The Validation group maintains a system that is capable of providing notification when critical validated facilities, equipment, systems, and processes requires requalification. 4.3 The Validation group is responsible for generation of a protocol and final report per SOP- XXXX to obtain approval and documented evidence of the requalification activities. SOP- XXXX provides guidance on the responsibility of the Validation Department and approval of the protocol and final report. 4.4 Validation, Quality Assurance (QA), and identified impacted departments are responsible for reviewing the summary reports and taking the appropriate actions as requested.

2 Document No.: SOP-XXXX Revision: XX Page 2 of DEFINITIONS 5.1 Key Performance Test A functional challenge that is indicative of the operation or performance of the particular system typically a part of the qualification. Performing a key performance test during the system requalification enables a more direct comparison of the current system operation relative to the validated state. These are identified in the applicable requalification procedures and protocols. 5.2 Last Significant Data Point Either the date of last data generated or the date of the reviewed lab test results. 5.3 Routine Periodic Recertification HEPA filters inside controlled areas are recertified following established schedules per SOP-XXXX Classified rooms/areas are recertified following established schedules per SOP-XXXX. 5.4 Revalidation/requalification are validations/qualifications performed as part of continued process verification to assure that the facilities, utilities, equipment and process remains in a state of control after changes or accumulated changes have been made or observed, or after certain period of time. At a minimum, the revalidation/requalification plan is to include a review of change control since the last validation, and functional challenge of the appropriate critical process variables or a review of routine monitoring as applicable. 5.5 User The functional area that principally utilizes, or is responsible (Owner) for, the equipment or facility. 6. PROCEDURE 6.1 General Once facilities and/or equipment have been validated, they are considered to be in a state of control. If validated conditions and control parameters remain unchanged, the system continues to operate in a validated state It is important for any significant change to be recognized and assessed before or at the time it occurs (refer to SOP-XXXX) so that appropriate action(s) can be taken to maintain a validated state Depending upon the assessment no additional validation or revalidation may be judged as necessary to demonstrate the suitable ongoing state of control for a given system Prospective testing is performed when something about the process, materials, equipment, operating parameters, or procedures, originally validated, has significantly changed in such a way as to put the validity of the validation work in question relative to the new status.

3 Document No.: SOP-XXXX Revision: XX Page 3 of CCR The Validation group performs CCR for major equipment, processes, and/or systems and summarizes the results in a CCR report. In instances where several changes were made in which each was identified separately to have "no impact" to the validation, the collective changes will be reviewed to reassure that a validated state has been maintained. These reviews may also initiate additional testing or data gathering activities (e.g., another change control) up to and including, when appropriate, a comprehensive revalidation As part of routine scheduled requalification, it is preferable that the CCR is performed prior to testing activity execution Access the Critical Changes/Repairs database and select the method for identifying the critical changes/repairs for the equipment, process and/or system that requires a review to be performed Review the critical changes/repairs that were performed during the period of the review that are not PM based (i.e., corrective work orders). Review the database list for the specified equipment, process, and/or system selected and obtain a copy of each Critical Change/Repair and associated Maintenance Work Order (MWO) performed Include in the review how many MWOs were generated and what they were for. Compare the number of MWOs and critical changes/repairs to determine the collective impact (if any) to the equipment, process, and/or system. Include this data in the summary report Determine if there were any related validation protocols, protocol addenda, and/or studies performed during the period of the review and assess relationship (if any) to any review trends Determine if there are any trends to the type and number of MWOs and critical changes/repairs that have occurred. If a trend is identified, discuss the findings with the impacted departments and QA to determine the appropriate action(s) to be taken. This data will be included in the summary report In the case of Preventative Maintenance (PM) work orders, determine if the applicable PM task(s) intervals are sufficient and make recommendations as needed based on work order history review Review pertinent quarterly EM trend reports, where applicable, to determine potential impact due to events against the equipment or system under review Review and evaluate the critical changes/repairs performed and determine the collective impact to the equipment, process and/or system (per SOP-XXXX) Generate a summary report that will consist of, but not be limited to, a summary of change control and/or MWO files reviewed, and evaluation of quarterly EM trend reports (if applicable).

4 Document No.: SOP-XXXX Revision: XX Page 4 of The summary report to be generated may be a stand-alone document, with its own distinct protocol number, or part of a revalidation package If the summary report identifies any adverse impact to the validated state of a process, environment, equipment, or utility, contact the impacted department(s) and QA to determine the appropriate action(s) to be taken When applicable, responsible individuals from impacted departments review the summary report to assess collective impact to their respective programs. 6.3 Revalidation For example, Maintenance reviews the summary report to assess any impact to the Maintenance programs (e.g., change in PM interval) For example, Engineering reviews the summary report to assess any impact to the Engineering programs (e.g., Engineering design or drawings) At the discretion of the Validation Services management, systems may be subjected to revalidation testing to address instances where the original (or previous) validation does not comply with current company and regulatory guidelines The need for revalidation may also be triggered by any of the following: The Change Control Program has determined that revalidation is necessary as a result of a change to a facility, equipment, system, or process An audit of the facility, equipment, system, or process indicates that revalidation is necessary An equipment-related Event investigation indicates that the operational state of the system may not be consistent with the original validation An assessment is performed every three years covering a six-year review period for all revalidation using the three-year revalidation module, with the exception of chambers where the review period currently covers only two years. The purpose is to determine if the totality of these minor changes impact the validate state of critical utilities, equipment, and systems The format, issuance, tracking and approval of validation protocols are described in SOP-XXXX. 6.4 Periodic Requalification Requalification of critical facilities, equipment and processes described in this procedure (i.e., with the greatest potential for product impact) is performed periodically beyond any revalidation resulting from change control.

5 Document No.: SOP-XXXX Revision: XX Page 5 of Requalification of equipment that is on a rotational basis (e.g., Building 001 Manufacturing autoclaves) is performed whereby system performance testing is scheduled for one unit which then triggers critical change review for the duplicate item to be performed at the same time Requalification activities may include prospective and/or concurrent testing, and/or a retrospective review of system performance data. The retrospective review should indicate that previous validation efforts meet current company standards, effective quality systems are in place, and effective change control is in place (e.g., via SOP-XXXX). Prospective or concurrent testing is performed to demonstrate that the system operation continues to be in a validated state of control If any test, acceptance criteria, or protocol requirement is not met, the activities are halted (as applicable) and deviation is generated in accordance with SOP-XXXX. 6.5 Requalification Schedule The management of Validation Services establishes the schedule to re-qualify a facility and equipment. Requalification is performed individually on a facility and equipment basis. When there are multiple pieces of equipment with identical functionality, testing is required for each piece of equipment unless there is an approved justification to utilize a bracketing or rotational approach. The CCR aspect, at minimum, should couple the piece of equipment being function tested The schedule for requalification is established based upon the critical nature of the facility and equipment in question and regulatory requirements. Without the documented approval of at least the system owner, Validation, and QA, the time period between requalification of the systems described in this procedure does not exceed the time specified in this procedure The requalification date is derived from the last significant data point in the current Validation review In the case of a CCR, the requalification date is derived from the QA approval date of the review The requalification schedule should allow for a 45 day review window, which includes the requalification testing, Validation review, and final report approval The appropriate Requalification review schedules (i.e., one-year or three-year Requalification) are added in database XYZ according to the frequency identified for facilities and equipment The testing specified for requalification may be conducted in conjunction with, or as part of, a separate CRRA or validation protocol. The evaluation of a change control may be on a different schedule from the documentation review but cannot exceed the frequency specified in this procedure to satisfy the requalification requirements.

6 Document No.: SOP-XXXX Revision: XX Page 6 of Requalification Execution The Validation Services Department prepares requalification forms (per appropriate SOP) or protocol (as needed) for the facility or equipment system in question prior to test execution Steam sterilization, depyrogenation and chamber requalification are executed per approved SOPs The minimum protocol requirements for critical systems are defined in the protocol and are approved per SOP-XXXX (which includes Quality Assurance) Any revisions to the approved protocol are subject to review by original signatories Requalification activities are executed under the direction of the Validation Department The requalification data are assembled and summarized in a final report by Validation Services. The report, executed protocol (as appropriate), and test data are submitted to the management of Validation Services or designee for review and approval Deviations and exceptions from the protocol procedure or acceptance criteria are documented in the final report The completed requalification final report is submitted for review and final approval. The approved final report is filed with the original validation package An assessment of the control system [i.e., PLC (programmable logic controller), data logger, MMI (man-machine interface)] for the system in question is performed according to SOP-XXXX and included in the requalification plan Critical Alarm(s) simulation will be performed (where applicable) as part of the requalification to verify functionality. Execution will follow pertinent forms per the individual procedures. 6.7 Requalification of Individual Systems Sterilization Systems Autoclaves and Dry Heat Ovens In addition to the annual autoclave Requalification all current autoclave commercial load configurations are individually requalified biennially (every two years). Each load is challenged using biological indicators (BIs) that are placed inside the load adjacent to the thermal sensor, e.g., thermocouples The requalification plan includes a review of related events, work orders, and change control documents generated for the equipment since the last validation/requalification Autoclave requalification function tests are performed in accordance with SOP-XXXX. The plan for autoclaves includes an empty chamber thermal distribution study to verify chamber temperature uniformity, and

7 Document No.: SOP-XXXX Revision: XX Page 7 of 12 an extended vacuum leak challenge to verify chamber seal integrity. The results of the requalification study are assessed with the data from the previous requalification, original, or most current validation for consistency In conjunction with the autoclave revalidation, an air removal test is performed at the beginning and end of the study and reviewed Depyrogenation ovens/tunnel requalification function tests are performed in accordance with SOP-XXXX. The requalification plan for depyrogenation ovens/tunnel includes a single loaded chamber heat distribution/penetration test run performed consistent with the original validation or most current requalification. The run includes endotoxin challenges that are placed inside the chamber adjacent to the thermal sensors. The results of the requalification study are assessed with the data from the previous requalification, original, or most current validation for consistency Steam-In-Place (SIP) Process The requalification of depyrogenation ovens/tunnel includes the acceptable integrity test results of the HEPA filters, if applicable In addition vial washing requalification is performed as part of the system since vial washing is always done concurrent with vial depyrogenation Each SIP process is evaluated annually (i.e., for tanks and lyophilizers). The thermal mapping/bi challenge must be repeated such that the locations are consistent with the most recent PQ Each equipment item is challenged annually e.g. each tank, each lyophilizer The requalification plan includes a review of related events, work orders, PM, and change control documents generated for the equipment since the last validation/ requalification The plan includes a single test run performed consistent with the original validation. The run includes biological indicators (BI) that are placed inside the system adjacent to the thermal sensors, e.g., thermocouples. At the end of the BI challenge, the BI Test must be performed within 4 hours. The results of the requalification study are assessed with the data from the previous requalification, original, or most current validation for consistency Controlled Temperature Storage Chambers/Warehouses Controlled storage chambers used to house in-process samples, finished product, stability samples, and/or approved components are evaluated every year for walk-in refrigerator and every two years for the

8 Document No.: SOP-XXXX Revision: XX Page 8 of 12 remainder (freezers and incubators). The evaluation includes a CCR and requalification. Chambers are qualified or requalified per SOP-XXXX, where temperature mapping (and humidity mapping as required) is performed along with review of related events, work orders, and change control documents generated for the equipment since the last validation/ requalification. Upon completion of any of the above procedure, summarize the data for the chamber (including hot and cold spot assessment) in a Final Report Controlled Storage Warehouses used to house in-process samples, finished product, stability samples, and/or approved components are evaluated every two years. The evaluation includes a CCR and requalification. Warehouses are qualified or requalified per SOP-XXXX, where temperature mapping (and humidity mapping as required) is performed along with review of related events, work orders, and change control documents generated for the equipment since the last validation/ requalification. Upon completion of any of the above procedure, summarize the data for the warehouse (including hot and cold spot assessment) in a Final Report If the requalification mapping results are acceptable and the CCR indicates no trends impacting the chamber/warehouse performance then the requalification is summarized and routed for approval. If the requalification mapping results are not acceptable or the CCR indicates a trend with potential impact to the chamber performance then an evaluation is performed. If the identified root cause requires a repair or adjustment impacting the chamber performance (temperature/humidity control or distribution) it must be documented by a work order and/or change control, and the requalification mapping must be repeated. The activities and results are summarized in the final report Controlled Manufacturing Areas (HVAC) HVAC systems are evaluated every three years, with a review period that covers six years. The cumulative review period is integrated into the CCR review period wherein a six-year time frame is evaluated The requalification plan includes a review of related events, work orders, and change control documents generated for the equipment since the last validation/ requalification A review of environmental monitoring data are included as part of Room Qualifications A comparison of the baseline and current HVAC Variable Frequency Drive (VFD) set point parameters is performed during requalification activities. An assessment of the state of control for the associated VFD set point parameters is performed.

9 Document No.: SOP-XXXX Revision: XX Page 9 of Critical Utility Systems WFI, RO Water, Pure Steam, CDA, Nitrogen Critical utility systems are evaluated every three years, with a review period that covers six years. The cumulative review period is integrated into the CCR review period wherein a six-year time frame is evaluated The requalification plan includes a review of related events, work orders, PM, and change control documents generated for the equipment since the last validation/ requalification Review the results of recent environmental monitoring for evidence of trends or routine excursions that may indicate a loss of system control. This review may be performed by Quality Control Microbiology as part of the review of environmental monitoring Clean steam attributes are confirmed annually Packaging Line Packaging lines are reviewed and evaluated annually for their impact on the validated processes The requalification plan includes a review of work orders, and change control documents generated for the equipment since the last validation/ requalification. A review of the packaging process as compared to the original process validation is also included as appropriate The equipment train includes all the major equipment on the packaging line Continued Verification of Process Validation Media Fill To maintain the state of control, continued verification of validated processes is performed annually. The continued verification of a process is performed for processes with an approved Standard Process Parameters (SPP) document The collective impact from change control, work orders, and events since the last validation or verification are reviewed in terms of their collective impact on the process performance. Revalidation can be performed as needed As part of continued verification, review the in-process data against the SPPs to evaluate process stability and capability As part of the process validation review, the process equipment train includes a review of the major equipment not already covered in this procedure Review of the process validation is segmented based on the processes listed in approved SPP documents.

10 Document No.: SOP-XXXX Revision: XX Page 10 of Media fills are reviewed annually to assess the current line configurations for the aseptic process The aseptic process is reviewed Commercial lots should be trended as part of the continued verification process, at minimum, to include the following items to ensure that the media fill program and commercial process are aligned: Sterile Hold Times Fill Duration Corrective Interventions Batch Size The trending data is captured from documents such as the MPRs and filling event log Room Qualification Classified rooms are periodically recertified and summarized Recertification/Requalification of existing/modified classified rooms includes, if applicable: A measurement of room air volumetric flow (air changes per hour) Air velocity (unidirectional flow areas only) HEPA filter leakage as appropriate Date of HEPA replacement and next due date for controlled areas Temperature, relative humidity, and room to room differential pressure A separate CCR is not required for classified rooms as environmental monitoring results to determine if an environment has drifted outside its normal operating range are trended and summarized Cleaning Validation Routine cleaning monitoring is performed and the frequency is governed per SOP-XXXX A review of the CIP process as compared to the original validation is also included as appropriate.

11 Document No.: SOP-XXXX Revision: XX Page 11 of ATTACHMENTS 7.1 Requalification Schedule 8. REVISION HISTORY Rev. XX Summary of Changes Update continue verification of process validation section to align with standard process parameters document. Delete process that has no SPP document on Attachment 7.1.

12 Document No.: SOP-XXXX Revision: XX Page 12 of 12 Title: REVALIDATION OF SYSTEMS, EQUIPMENT, AND PROCESSES Attachment 7.1 The systems listed in the table below is intended to be a representation of types of equipments or systems incorporated into the requalification schedule at the site. BUILDING TYPE CURRENT SYSTEMS REQUALIFICATION SCHEDULE REFERENCE DOCUMENTS Steam Sterilization Autoclaves Lyophilizer Tank SIP Annually 002 Dry Heat Depyrogenatio n Dry Heat Oven Depyrogenation Tunnel Annually HVAC HVAC & Critical Utilities RO WFI PS Nitrogen 3 years (Note: this CCR covers a 6 year review period) CDA

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

FDA and the Compounding Pharmacy

FDA and the Compounding Pharmacy FDA and the Compounding Pharmacy Scott Sutton, Ph.D. scott.sutton@microbiol.org 41 Overview of Presentation The Recent Events GCP and GMP Basics the 483 Review H.R. 3204 Outsourcing Facility Preparation

More information

What is Process Validation?

What is Process Validation? What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process

More information

TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS

TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS APPLICATION NOTE CC-105 (US) Introduction This application note will demonstrate how real-time viable particle count data will

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE

More information

Particle Monitoring Requirements in Pharmaceutical Cleanrooms

Particle Monitoring Requirements in Pharmaceutical Cleanrooms Particle Monitoring Requirements in Pharmaceutical Cleanrooms All drugs must be manufactured in accordance with the current Good Manufacturing Practice (cgmp) regulations. Pharmaceutical manufacturers

More information

Steam Sterilization and the 2007 Revision of PDA Technical Report 1

Steam Sterilization and the 2007 Revision of PDA Technical Report 1 Steam Sterilization and the 2007 Revision of PDA Technical Report 1 14 November 2007 Presented By: Mike Finger (Tunnell Consulting) Don Drew (Abbott Bioresearch Center) Agenda: Introduction Sterilization

More information

OPERATIONAL STANDARD

OPERATIONAL STANDARD 1 of 11 1. Introduction The International Safe Transit Association (ISTA), a non-profit association whose objective is to prevent product damage and excess packaging usage within the distribution environment.

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:

More information

EU GMP Annex 1 Update 2008: Airborne Particle Counting

EU GMP Annex 1 Update 2008: Airborne Particle Counting EU GMP Annex 1 Update 2008: Airborne Particle Counting Airborne Particle Counting for Pharmaceutical Facilities: Update 2008, EU GMP Annex 1 Morgan Polen - VP of Applications Technology, Lighthouse Worldwide

More information

White Paper. Life Sciences Industry Solution Blueprint for Environmental Monitoring Systems (EMS) ISPE Guidance and Best Practices.

White Paper. Life Sciences Industry Solution Blueprint for Environmental Monitoring Systems (EMS) ISPE Guidance and Best Practices. White Paper Life Sciences Industry Solution Blueprint for Environmental Monitoring Systems (EMS) Author: Roberto Zerbi, Global Industries Solutions Life Sciences, Invensys What s Inside: 1. Introduction

More information

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known

More information

Qualification, calibration and maintenance of stability chambers. Dr. Mathias Kramer

Qualification, calibration and maintenance of stability chambers. Dr. Mathias Kramer Qualification, calibration and maintenance of stability chambers Dr. Mathias Kramer Agenda 1. Qualification of stability chambers 2. Calibration of equipment of stability chambers 3. Maintenance of stability

More information

Regulations Concerning

Regulations Concerning Regulations Concerning Airborne Particle Counting Two types of activities performed with an airborne particle counter: Classification focuses primarily on the environment Particle Counting Applications

More information

US Environmental Protection Agency Office of Pesticide Programs

US Environmental Protection Agency Office of Pesticide Programs US Environmental Protection Agency Office of Pesticide Programs Office of Pesticide Programs Microbiology Laboratory Environmental Science Center, Ft. Meade, MD Standard Operating Procedure for Monitoring

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION 1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information

More information

VALIDATION OF ASEPTIC PROCESSES

VALIDATION OF ASEPTIC PROCESSES PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 007-6 1 January 2011 RECOMMENDATION ON THE VALIDATION OF ASEPTIC PROCESSES PIC/S January 2011 Reproduction prohibited

More information

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Working document QAS/03.055/Rev.2 RESTRICTED SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION This document has followed

More information

A WHO guide to good manufacturing practice (GMP) requirements

A WHO guide to good manufacturing practice (GMP) requirements WHO/VSQ/97.02 ENGLISH ONLY DISTR.: LIMITED A WHO guide to good manufacturing practice (GMP) requirements Part 2: Validation Written by: Gillian Chaloner-Larsson, Ph.D, GCL Bioconsult, Ottawa Roger Anderson,

More information

Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III

Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III BY DAVID W. VINCENT AND HERBERT MATHESON HEATING, VENTILATION, AND AIR CONDITIONING (HVAC) SYSTEMS INTRODUCTION

More information

Guideline on Process Validation

Guideline on Process Validation 1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /

More information

Guidance on Qualification of existing facilities, systems, equipment and utilities

Guidance on Qualification of existing facilities, systems, equipment and utilities QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3

More information

FAT Factory Acceptance Testing SAT Site Acceptance Testing

FAT Factory Acceptance Testing SAT Site Acceptance Testing FAT Factory Acceptance Testing SAT Site Acceptance Testing Dr. Ingrid Walther May 2015, Page 1 Factory Acceptance Testing - FAT Site Acceptance Testing - SAT FAT and SAT - Important Milestones in the Project

More information

OVERVIEW OF STANDARD 7E & STANDARD 20

OVERVIEW OF STANDARD 7E & STANDARD 20 Standard for Thermal Transport Packaging Used in Parcel Delivery System Shipment 7E 2 010 ISTA 7E Usage Modes VERSION DATE OCTOBER 2010 Initial Release ISTA, Distributing Confidence, Worldwide ISTA 7-Series

More information

Annex 4 Supplementary guidelines on good manufacturing practices: validation

Annex 4 Supplementary guidelines on good manufacturing practices: validation World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 4 Supplementary guidelines on good manufacturing practices: validation 1. Introduction 2. Scope 3. Glossary 4. Relationship between

More information

ENVIRONMENTAL MONITORING

ENVIRONMENTAL MONITORING ENVIRONMENTAL MONITORING Assessment and verification of the adequacy of the aseptic compounding environment is essential. Environmental monitoring programs are designed to promptly identify potential sources

More information

Process Validation for Medical Devices

Process Validation for Medical Devices Process Validation for Medical Devices Dan O Leary CBA, CQE, CRE, CSSBB, CIRM, LLC 603-209-0600 OmbuEnterprises@msn.com Copyright 2010 by, LLC Process Validation for Medical Devices 1 Instructor Introduction

More information

Monitoring manufacturing, production and storage environments in the pharmaceutical industry

Monitoring manufacturing, production and storage environments in the pharmaceutical industry Application Description AD/RandC/005-EN Monitoring manufacturing, production and storage environments in the pharmaceutical industry - Provides independent verification and validation of the manufacture,

More information

New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2

New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 This white paper describes the changes outlined in the Draft International Standard (DIS) editions of ISO 14644-1 and ISO 14644-2.

More information

Media fills Periodic performance qualification (Re-Validation)

Media fills Periodic performance qualification (Re-Validation) Media fills Periodic performance qualification (Re-Validation) Minimum number of Simulations Number of units Contaminated Units Action a Two per Year (Retrospective & Prospective Validation) < 5000 5000

More information

and Drug Administration/Office of Regulatory Affairs (FDA/ORA) laboratories.

and Drug Administration/Office of Regulatory Affairs (FDA/ORA) laboratories. Page 1 of 13 Sections Included in this Document and Change History 1. Purpose 2. Scope 3. Responsibilities 4. Background 5. References 6. Procedure/(6.C.4. added or electronically ) 7. Definitions 8. Records

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

(WHO Technical Report Series, No. 961, 2011), Annex 9. Temperature and humidity monitoring systems for fixed storage areas 107

(WHO Technical Report Series, No. 961, 2011), Annex 9. Temperature and humidity monitoring systems for fixed storage areas 107 Annex 5 Technical supplements to Model guidance for the storage and transport of timeand temperature-sensitive pharmaceutical products (WHO Technical Report Series, No. 961, 2011), Annex 9 1. The technical

More information

Case Study Neubau einer Parenteralia Fabrik 3. GMP-Forum, Kirchzarten 28. September 2012, Basel. Philip Schneider, F.

Case Study Neubau einer Parenteralia Fabrik 3. GMP-Forum, Kirchzarten 28. September 2012, Basel. Philip Schneider, F. 3. GMP-Forum, Kirchzarten 28. September 2012, Basel Philip Schneider, F. Hoffmann-La Roche Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing

More information

White paper: FDA Guidance for Industry Update Process Validation

White paper: FDA Guidance for Industry Update Process Validation White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,

More information

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities September 2, 2003 Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities Purpose This document provides a summary of the requirements relating to use of computer-based systems in activities

More information

All Processes Dr. Paul Ruffieux Consultant

All Processes Dr. Paul Ruffieux Consultant PSI-L Isolator Platform All Processes Dr. Paul Ruffieux Consultant 1 Requirements Is it possible to have one Isolator for Filling under aseptic conditions (Grade A) Use of isolator technology in ISO8 room

More information

German engineering under high pressure

German engineering under high pressure German engineering under high pressure Over 25 years of experience as a manufacturer of sterilizers, autoclaves and lyophilization systems for laboratories, production and research Production-scale autoclaves

More information

Audit Report in the framework of the APIC Audit Programme

Audit Report in the framework of the APIC Audit Programme Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

AS9100 Quality Manual

AS9100 Quality Manual Origination Date: August 14, 2009 Document Identifier: Quality Manual Revision Date: 8/5/2015 Revision Level: Q AS 9100 UNCONTROLLED IF PRINTED Page 1 of 17 1 Scope Advanced Companies (Advanced) has established

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information

Monitoring the autoclaving process in the pharmaceutical industry

Monitoring the autoclaving process in the pharmaceutical industry Application Description AD/RandC/006-EN Monitoring the autoclaving process in the pharmaceutical industry - Provides independent verification and validation monitoring of the autoclaving process - Enables

More information

Narlin B. Beaty, Ph.D. Page 1 Chesapeake Biological Laboratories, Inc.

Narlin B. Beaty, Ph.D. Page 1 Chesapeake Biological Laboratories, Inc. Incremental Addition of Parenteral Capacity Case Study for a Lyophilizer Filling parenterals is capital intensive, with large, fixed ongoing maintenance fees to support continuous operations. There is

More information

CHAPTER 7: QUALITY CONTROL/QUALITY ASSURANCE ***DRAFT***

CHAPTER 7: QUALITY CONTROL/QUALITY ASSURANCE ***DRAFT*** CHAPTER 7: QUALITY CONTROL/QUALITY ASSURANCE ***DRAFT*** CHAPTER 7: QUALITY CONTROL/QUALITY ASSURANCE... 1 SECTION 7.1 INTRODUCTION... 2 Subsection 7.1.1 Purpose... 2 Subsection 7.1.2 Scope... 2 Subsection

More information

How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs

How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs WHITE PAPER 7004 How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs By John Boehm Business Unit Manager Colder Products Company Today s

More information

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

Design, Operation and Management of GTP/GMP Cell Engineering Facilities Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based

More information

FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS

FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS Presented By Clay Anselmo, R.A.C. President and C.O.O. Reglera L.L.C. Denver, CO Learning Objectives Understand the Definitions of Failure Investigation and

More information

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Guidance for Industry Current Good Manufacturing Practice Interim Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act DRAFT GUIDANCE This guidance document is

More information

Raleigh, NC May 12 th & 13 th 2016. Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply?

Raleigh, NC May 12 th & 13 th 2016. Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply? Raleigh, NC May 12 th & 13 th 2016 Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply? The International Cleanroom Standards (ISO 14644-1 & 2) have been updated, these

More information

Cold Chain Shipping: Protecting Temperature Sensitive Products. Diane McLean Pfizer Global Manufacturing

Cold Chain Shipping: Protecting Temperature Sensitive Products. Diane McLean Pfizer Global Manufacturing Cold Chain Shipping: Protecting Temperature Sensitive Products Diane McLean Pfizer Global Manufacturing January 8, 2009 1 What is Cold Chain? The term cold chain or cold chain management refers to controlled

More information

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Cleanroom. For. Sterile Manufacturing Facilities

Cleanroom. For. Sterile Manufacturing Facilities Cleanroom For Sterile Manufacturing Facilities Praphon Angtrakool Food and Drug Administration 1 WHO TRS No. 823 Annex 1, 1992 (1) General 17.1 The production of sterile preparations should be carried

More information

COPY. Revision History: Changes were made to reflect the current practice of only including the most recent changes in the revision history.

COPY. Revision History: Changes were made to reflect the current practice of only including the most recent changes in the revision history. Revision History COPY The top row of this table shows the most recent changes to this controlled document. For previous revision history information, archived versions of this document are maintained by

More information

PROCEDURE FOR FRESH APPLE AND PEAR EXPORTS FROM SOUTH AFRICA TO MEXICO. Responsibility: Service Manager: Special Shipments Name: Initial:

PROCEDURE FOR FRESH APPLE AND PEAR EXPORTS FROM SOUTH AFRICA TO MEXICO. Responsibility: Service Manager: Special Shipments Name: Initial: Page 1 of 10 Rev: 0 1. Reference 1.1 This procedure refers to the cold treatment of fruit flies and Eastern fruit moth in apples and pears, as prescribed by the Secretariat of Agriculture, Cattle and Rural

More information

Water for Injection (WFI) and Pure Steam Production in a Lean Manufacturing Environment. Larry Zanko Project Manager STERIS Corporation

Water for Injection (WFI) and Pure Steam Production in a Lean Manufacturing Environment. Larry Zanko Project Manager STERIS Corporation Water for Injection (WFI) and Pure Steam Production in a Lean Manufacturing Environment Larry Zanko Project Manager STERIS Corporation Agenda Brief overview of multiple-effect water stills (MWS) Lean advancements

More information

ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers A WHITE PAPER

ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers A WHITE PAPER A WHITE PAPER ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers By Scott Mackin A WHITE PAPER ENVIRONMENTAL TESTING & MONITORING:

More information

On-Site GMP Training GMP COMPLIANCE TECHNICAL

On-Site GMP Training GMP COMPLIANCE TECHNICAL PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program

More information

Key energy-efficient features of your new home

Key energy-efficient features of your new home Key energy-efficient features of your new home Your thermal envelope The thermal envelope, or shell, of your home (walls, roof and floor) is designed to keep you dry and comfortable. It protects you from

More information

Steam Sterilization Cycles for Lab Applications

Steam Sterilization Cycles for Lab Applications Steam Sterilization Cycles for Lab Applications Presented by Gary Butler STERIS Life Sciences August 2009 Early Steam Sterilizers Koch Upright Sterilizer First Pressurized Sterilizer First built by Pasteur-Chamberlain

More information

Backup Fuel Oil System Decommissioning & Restoration Plan

Backup Fuel Oil System Decommissioning & Restoration Plan Backup Fuel Oil System Page 1 of 19 Overview of Physical Fuel Oil System and Decommissioning Steps The fuel oil system at Milford Power consists of a number of subsystems. These include the following:

More information

Best-Practice Guide Pharmaceutical-Chain Temperature Control and Recording

Best-Practice Guide Pharmaceutical-Chain Temperature Control and Recording Best-Practice Guide Pharmaceutical-Chain Temperature Control and Recording Introduction Medicinal products require controlled storage and transit conditions in order to ensure that their quality is not

More information

Smart. Scalable. Simple.

Smart. Scalable. Simple. Thermo Scientific Wireless Monitoring Solution Smart. Scalable. Simple. providing the protection you need with the simplicity you deserve Thermo Scientific Wireless Monitoring Solution Optimized Sample

More information

NSW Air Quality Monitoring Network: Quality Assurance Procedures

NSW Air Quality Monitoring Network: Quality Assurance Procedures NSW Air Quality Monitoring Network: Quality Assurance Procedures Copyright State of NSW and Office of Environment and Heritage With the exception of photographs, the State of NSW and Office of Environment

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

TG 47-01. TRANSITIONAL GUIDELINES FOR ISO/IEC 17021-1:2015, ISO 9001:2015 and ISO 14001:2015 CERTIFICATION BODIES

TG 47-01. TRANSITIONAL GUIDELINES FOR ISO/IEC 17021-1:2015, ISO 9001:2015 and ISO 14001:2015 CERTIFICATION BODIES TRANSITIONAL GUIDELINES FOR ISO/IEC 17021-1:2015, ISO 9001:2015 and ISO 14001:2015 CERTIFICATION BODIES Approved By: Senior Manager: Mpho Phaloane Created By: Field Manager: John Ndalamo Date of Approval:

More information

Computer-Aided Facilities Management - A Logical Trend

Computer-Aided Facilities Management - A Logical Trend Computer-Aided Facilities Management - A Logical Trend Two major organisational changes are part of the modern pharmaceutical industry scene. Firstly, mergers as companies seek to consolidate resources

More information

Critical review on qualification of sterilization equipment in aseptic processing

Critical review on qualification of sterilization equipment in aseptic processing Review article ISSN 2321-0125 www.jpbs-online.com Critical review on qualification of sterilization equipment in aseptic processing Sachin J. Shinde 1, Pritam S. Jain* 2, Nikita K. Kale 1 1 Department

More information

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV WHO/VSQ/97.03 Original: English Distribution: General *XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV 3UHSDUHGE\*LOOLDQ&KDORQHU/DUVVRQ3K'*&/%LRFRQVXOW 2WWDZD&DQDGD /LQNWR&RQWHQWVSDJH GLOBAL PROGRAMME

More information

Pharmagraph. GMP/GLP Monitoring System

Pharmagraph. GMP/GLP Monitoring System Pharmagraph GMP/GLP Monitoring System Pharmagraph GMP/GLP Monitoring System Demonstrates GMP/GLP compliance for cleanrooms and laboratories Monitors, Alarms, Logs and Reports Airborne particle counts,

More information

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new

More information

QUALITY MANUAL REVISION RECORD

QUALITY MANUAL REVISION RECORD Page 2 of 31 REVISION RECORD Date Rev Description Jun 18, 2007 N/C Original Issue Sep 16, 2009 A Update to ISO 9001:2008 Standard. Feb 04, 2010 B Revised exclusions, removed (Except 7.3.7 from the exclusion

More information

North American Electric Reliability Corporation: Critical Infrastructure Protection, Version 5 (NERC-CIP V5)

North American Electric Reliability Corporation: Critical Infrastructure Protection, Version 5 (NERC-CIP V5) Whitepaper North American Electric Reliability Corporation: Critical Infrastructure Protection, Version 5 (NERC-CIP V5) NERC-CIP Overview The North American Electric Reliability Corporation (NERC) is a

More information

FDA Guidance for Industry Update - Process Validation

FDA Guidance for Industry Update - Process Validation FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead

More information

Top 10 considerations when validating an autoclave

Top 10 considerations when validating an autoclave Top 10 considerations when validating an autoclave Validating an autoclave is a daunting and time-consuming task. This white paper details the tricks, tips and traps to such a validation project from how

More information

Testing Automated Manufacturing Processes

Testing Automated Manufacturing Processes Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls

More information

ANY TISSUE BANK USA. Revision: 3

ANY TISSUE BANK USA. Revision: 3 1 of 5 1. Scope 1.1. This work instruction provides specific direction for qualifying vendors as required in SOP-5, Purchasing Components. 2. Definitions and Acronyms 2.1. Definitions for terms used in

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

Microbiological Laboratory Quality Assurance

Microbiological Laboratory Quality Assurance Microbiological Laboratory Quality Assurance Laboratory quality assurance A group of activities proceeded in order to ensure the validity of test results Laboratory quality assurance according to ISO/IEC17025

More information

A Stability Program for the Distribution of Drug Products

A Stability Program for the Distribution of Drug Products A Stability Program for the Distribution of Drug Products Teresa I. Lucas*, Rafik H. Bishara, and Robert H. Seevers Drug products must be transported in a manner that ensures products will be maintained

More information

White Paper. The Gap Between LIMS Capabilities and Environmental Monitoring Needs. Abstract. The Environmental Monitoring Workflow

White Paper. The Gap Between LIMS Capabilities and Environmental Monitoring Needs. Abstract. The Environmental Monitoring Workflow The Gap Between LIMS Capabilities and Environmental Monitoring Needs Abstract White Paper While laboratory tests are an important part of Environmental Monitoring (EM) operations, the EM workflow is complex

More information

Benefits of Cold Aisle Containment During Cooling Failure

Benefits of Cold Aisle Containment During Cooling Failure Benefits of Cold Aisle Containment During Cooling Failure Introduction Data centers are mission-critical facilities that require constant operation because they are at the core of the customer-business

More information

PROPOSED ADDENDA TO EPA/AUTO PROTOCOL FOR COMPLIANCE ASSURANCE MONITORING

PROPOSED ADDENDA TO EPA/AUTO PROTOCOL FOR COMPLIANCE ASSURANCE MONITORING This document presents procedures that satisfy EPA Compliance Assurance Monitoring (CAM) rule requirements applicable to VOC (Volatile Organic Compound) emission control devices for coating processes for

More information

Owner s Manual. Walk-in Monitoring System 100. Cooler is Better! TM. Used in UL Listed Door Panel Assemblies

Owner s Manual. Walk-in Monitoring System 100. Cooler is Better! TM. Used in UL Listed Door Panel Assemblies REV. G Cooler is Better! TM Owner s Manual Walk-in Monitoring System 100 Used in UL Listed Door Panel Assemblies American Panel Corporation 5800 S.E. 78th Street, Ocala, Florida 34472-3412 Phone: (352)

More information

A. The Commissioning Authority (CxA) has been contracted or will be contracted directly with the Owner for this project.

A. The Commissioning Authority (CxA) has been contracted or will be contracted directly with the Owner for this project. DIVISION 23 HEATING, VENTILATING, AND AIR CONDITIONING (HVAC) SECTION 23 08 02 PART 1 GENERAL 1.01 AUTHORITY (CxA) A. The Commissioning Authority (CxA) has been contracted or will be contracted directly

More information

A Truck Driver s Guide to Care and Maintenance of Diesel Particulate Filters (DPFs)

A Truck Driver s Guide to Care and Maintenance of Diesel Particulate Filters (DPFs) A Truck Driver s Guide to Care and Maintenance of Diesel Particulate Filters (DPFs) Disclaimer: This handbook is not a substitute for the detailed instructions/warranty limitations supplied by the manufacturer

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

ALACC Frequently Asked Questions (FAQs)

ALACC Frequently Asked Questions (FAQs) Updated October 17, 2012 ALACC Contents Web Introduction to FAQ... 2 FAQ #6... 3 ALACC Section: How to Meet ISO 17025 Requirements for Method Verification (Page 9)... 3 FAQ #13... 4 ALACC Section ALACC

More information

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR WHO/FWC/IVB/QSS/VQR 2011 This guidance document GUIDE TO MASTER FORMULAE is one of a series developed by WHO/FWC/IVB Quality, Safety & Standards team upon request from the manufacturers members of the

More information

Control Device Requirements Charts For Oil and Gas Handling and Production Facilities

Control Device Requirements Charts For Oil and Gas Handling and Production Facilities Device Charts For Oil and Gas Handling and Production Facilities Purpose/Scope: The purpose of this document is to provide standardized guidance for use by the regulated community and air permit reviewers,

More information

Texas Commission on Environmental Quality Page 1 Chapter 117 - Control of Air Pollution from Nitrogen Compounds

Texas Commission on Environmental Quality Page 1 Chapter 117 - Control of Air Pollution from Nitrogen Compounds Texas Commission on Environmental Quality Page 1 SUBCHAPTER G: GENERAL MONITORING AND TESTING REQUIREMENTS DIVISION 1: COMPLIANCE STACK TESTING AND REPORT REQUIREMENTS 117.8000, 117.8010 Effective June

More information

ISO 9001:2015 Internal Audit Checklist

ISO 9001:2015 Internal Audit Checklist Page 1 of 14 Client: Date: Client ID: Auditor Audit Report Key - SAT: Satisfactory; OBS: Observation; NC: Nonconformance; N/A: Not Applicable at this time Clause Requirement Comply Auditor Notes / Evidence

More information

CHAPTER 7 QUALITY ASSESSMENT

CHAPTER 7 QUALITY ASSESSMENT CHAPTER 7 QUALITY ASSESSMENT Chapter 7 QUALITY ASSESSMENT 7.1 OVERVIEW OF CBB-SPECIFIC QUALITY ASSURANCE/QUALITY CONTROL PROGRAM An extensive, site-specific Quality Assurance/Quality Control (QA/QC) program

More information

Environmental Chamber. Stability/ GMP 2000 Series. Stability Testing Chambers

Environmental Chamber. Stability/ GMP 2000 Series. Stability Testing Chambers GMP 2000 Series ISO 9001:2000 21 CFR PART 11 COMPLIANCE SOFTWARE Stability/ Environmental Chamber Stability Testing Chambers Walk-in Test Chambers for Stability Tests on Pharmaceutical Products according

More information

GMP AUDIT CHECKLIST (AS PER WHO GUIDELINES) Page 1 of 32 INSPECTION OF:

GMP AUDIT CHECKLIST (AS PER WHO GUIDELINES) Page 1 of 32 INSPECTION OF: GMP AUDIT CHECKLIST (AS PER WHO GUIDELINES) Page 1 of 32 Full Address of Company: Products manufactured Location of production Inspection type: mark all that apply external { } routine { } concise { }

More information